EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Effectiveness of a Mobile App (Meds@HOME) to Improve Medication Safety for Children With Medical Complexity: Protocol for a Randomized Controlled Trial

Wirksamkeit einer mobilen App (Meds@HOME) zur Verbesserung der Medikationssicherheit für Kinder mit komplexen Erkrankungen: Protokoll einer randomisierten kontrollierten Studie

Nicole E Werner iD, Makenzie Morgen iD, Sophie Kooiman iD, Anna Jolliff iD, Gemma Warner iD, James Feinstein iD, Michelle Chui iD, Barbara Katz iD, Brittany Storhoff iD, Kristan Sodergren iD, Ryan Coller iD

JMIR Research Protocols · 2024-09-09 · 13 · e60621

DOI: 10.2196/60621 ↗

Auf einen Blick

Das Protokoll beschreibt eine 6-monatige randomisierte Studie zu Meds@HOME bei Kindern mit komplexen Erkrankungen. Geprüft wird, ob die App die Genauigkeit der Medikamentengabe verbessert.

Fragestellung

Verbessert die Meds@HOME-App die Genauigkeit der Medikamentengabe bei primären und sekundären Betreuungspersonen von Kindern mit komplexen Erkrankungen?

Methode

Randomisierte kontrollierte Studie; Rekrutierung von bis zu 152 PCGs und 304 SCGs; 1:1-Zuteilung über 6 Monate; Vergleich mit Kontrolle ohne Meds@HOME.

Ergebnisse

94/152 (62 %) PCGs wurden bis 15. Mai 2024 eingeschlossen. Die Studie läuft; Ergebnisse werden nach Abschluss der Auswertung erwartet.

Schlussfolgerung der Autor:innen

Die Meds@HOME-App ist laut Autor:innen ein vielversprechender Ansatz zur Verbesserung der Medikationssicherheit bei PCGs von CMC mit Hochrisikomedikamenten.

Kernaussagen

  • Protokoll einer randomisierten Studie zu Meds@HOME
  • Primärer Endpunkt: Genauigkeit der Medikamentengabe der PCGs
  • Sekundär: SCG-Genauigkeit, Nutzung von Klinik/Notaufnahme und Adhärenz

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2024-09-09. Written by Nicole E Werner and 10 co-authors. Institution: Indiana University School of Public Health-Bloomington, Bloomington, IN, United States. Major MEDLINE topics: Mobile Applications. Cited 11 times so far (Crossref); 39 references. The full text is freely available in PubMed Central. Funded by: AHRQ HHS, NCATS NIH HHS.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

This study will pilot-test the mobile app, Medication Safety @HOME—Meds@HOME intervention to improve medication administration accuracy, reduce preventable adverse drug events, and ultimately improve chronic care management for children with medical complexity (CMC). The Meds@HOME app was co-designed with CMC families, secondary caregivers (SCGs), and health professionals to support medication management for primary caregivers (PCGs) and SCGs of CMC. We hypothesize that Meds@HOME will improve caregivers’ medication administration accuracy, reduce preventable adverse drug events, and ultimately improve chronic care management.

Objective

This study aims to evaluate the effectiveness of Meds@HOME on medication administration accuracy for PCGs and SCGs.

Methods

This study will recruit up to 152 PCGs and 304 SCGs of CMC who are prescribed at least 1 scheduled high-risk medication and receive care at the University of Wisconsin American Family Children’s Hospital. PCGs will be randomly assigned, for the 6-month trial, to either the control group (not trialing Meds@HOME) or the intervention group (trialing Meds@HOME) using 1:1 ratio. The Meds@HOME app allows caregivers to create a child profile, store medication and care instructions, and receive reminders for upcoming and overdue care routines and medication refills. Surveys completed both at the start and end of the trial measure demographics, medication delivery knowledge, confidence in the CMC’s caregiving network, and comfort with medical information. Univariate and multivariate generalized estimation equations will be used for primary statistical analysis. The primary outcome is the PCG’s rate of medication administration accuracy measured as correct identification of each of the following for a randomly selected high-risk medication: indication, formulation, dose, frequency, and route at baseline and after 6 months. Secondary outcomes include SCG medication administration accuracy (indication, formulation, dose, frequency, and route), count of University of Wisconsin hospital and emergency department encounters, PCG-reported medication adherence, count of deaths, and PCG medication confidence and understanding.

Results

Recruitment for this study began on November 29, 2023. As of May 15, 2024, we have enrolled 94/152 (62%) PCGs. We expect recruitment to end by August 1, 2024, and the final participant will complete the study by January 28, 2025, at which point we will start analyzing the complete responses. We expect publication of results at the end of 2025.

Conclusions

The Meds@HOME mobile app provides a promising strategy for improving PCG medication safety for CMC who take high-risk medications. In addition, this protocol highlights novel procedures for recruiting SCGs of CMC. In the future, this app could be used more broadly across diverse caregiving networks to navigate complex medication routines and promote medication safety. Trial Registration ClinicalTrials.gov NCT05816590; https://clinicaltrials.gov/study/NCT05816590 International Registered Report Identifier (IRRID) DERR1-10.2196/60621

Subjects

MeSH terms (MEDLINE)

Mobile ApplicationsChildFemaleHumansMaleCaregiversDrug-Related Side Effects and Adverse ReactionsMedication ErrorsRandomized Controlled Trials as Topic

Author keywords

caregivingchildren with medical complexitymedication managementmedication safetypolypharmacy

Authors and institutions

  • Indiana University School of Public Health-Bloomington, Bloomington, IN, United States.
  • University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States.
  • University of Colorado School of Medicine, Aurora, CO, United States.
  • University of Wisconsin-Madison School of Pharmacy, Madison, WI, United States.
  • Family Voices of Wisconsin, Madison, WI, United States.

ORCID profiles: Nicole E Werner, Makenzie Morgen, Sophie Kooiman, Anna Jolliff, Gemma Warner, James Feinstein, Michelle Chui, Barbara Katz, Brittany Storhoff, Kristan Sodergren, Ryan Coller

Funding

  • AHRQ HHS
  • NCATS NIH HHS

Cite

APA

Werner, N. E., Morgen, M., Kooiman, S., Jolliff, A., Warner, G., Feinstein, J., Chui, M., Katz, B., Storhoff, B., Sodergren, K., & Coller, R. (2024). Effectiveness of a Mobile App (Meds@HOME) to Improve Medication Safety for Children With Medical Complexity: Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 13, e60621. https://doi.org/10.2196/60621

Vancouver

Werner NE, Morgen M, Kooiman S, Jolliff A, Warner G, Feinstein J, et al. Effectiveness of a Mobile App (Meds@HOME) to Improve Medication Safety for Children With Medical Complexity: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2024;13:e60621. doi:10.2196/60621

BibTeX
@article{Werner2024,
  author = {Werner, Nicole E and Morgen, Makenzie and Kooiman, Sophie and Jolliff, Anna and Warner, Gemma and Feinstein, James and Chui, Michelle and Katz, Barbara and Storhoff, Brittany and Sodergren, Kristan and Coller, Ryan},
  title = {Effectiveness of a Mobile App (Meds@HOME) to Improve Medication Safety for Children With Medical Complexity: Protocol for a Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2024},
  volume = {13},
  pages = {e60621},
  doi = {10.2196/60621}
}
Start for free →